Biweekly cetuximab and first-line chemotherapy in chinese patients with k-ras wild-type colorectal cancers

BACKGROUND: The efficacy and safety of using combination chemotherapy with cetuximab as first-line treatment in patients with K-ras wild-type colorectal cancers has been well established. In general, weekly cetuximab was given with biweekly chemotherapy FOLFOX-4 or FOLFIRI, synchronizing them would...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Chan, Wing-Lok, Lee, Victor Ho Fun, Siu, Wai Kwan Steven, Ho, Pui Ying Patty, Liu, Rico King Yin, Leung, To Wai
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Medknow Publications & Media Pvt Ltd 2014
Gaiak:
COLORECTAL CANCER: Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4134610/
https://ncbi.nlm.nih.gov/pubmed/25136526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2278-330X.136802
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak